|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.00618702
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
0.00240735
|
|
|
IGAN1
|
[NCBI]
|
0.00232327
|
|
|
EEC1
|
[NCBI]
|
0.00138988
|
|
|
MCP
|
[NCBI]
|
0.00130137
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00105525
|
|
|
SPS
|
[NCBI]
|
0.000639614
|
|
|
C3
|
[NCBI]
|
0.000636574
|
|
|
complement component 2 deficiency
|
[NCBI]
|
0.000417386
|
|
|
HAE
|
[NCBI]
|
0.000396122
|
|
|
MBL2
|
[NCBI]
|
0.000344847
|
|
|
C4B
|
[NCBI]
|
0.000341085
|
|
|
complement factor i deficiency
|
[NCBI]
|
0.000312018
|
|
|
complement component 5 deficiency
|
[NCBI]
|
0.000312018
|
|
|
aHUS
|
[NCBI]
|
0.000302163
|
|
|
CFB
|
[NCBI]
|
0.000210869
|
|
|
CF
|
[NCBI]
|
0.000188697
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000183694
|
|
|
CFH
|
[NCBI]
|
0.000168613
|
|
|
CFD
|
[NCBI]
|
0.000168491
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
0.000163092
|
|
|
complement factor h deficiency
|
[NCBI]
|
0.000156593
|
|
|
complement component 7 deficiency
|
[NCBI]
|
0.000156593
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
0.000149072
|
|
|
CD59
|
[NCBI]
|
0.000137918
|
|
|
complement component 6 deficiency
|
[NCBI]
|
0.000127327
|
|
|
FCAS
|
[NCBI]
|
0.000116766
|
|
|
HLA-A
|
[NCBI]
|
0.000116559
|
|
|
vibratory angioedema
|
[NCBI]
|
0.000112951
|
|
|
hypersensitivity pneumonitis, familial
|
[NCBI]
|
0.000112951
|
|
|
monocyte chemotactic disorder
|
[NCBI]
|
0.000112951
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
0.000112951
|
|
|
PFC
|
[NCBI]
|
9.0974e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
8.5161e-05
|
|
|
CD55
|
[NCBI]
|
7.19687e-05
|
|
|
immunodeficiency, partial combined, with absence of hla determinants and beta-2-microglobulin from lymphocytes
|
[NCBI]
|
6.97578e-05
|
|
|
C7
|
[NCBI]
|
6.31044e-05
|
|
|
carboxypeptidase n deficiency
|
[NCBI]
|
6.21752e-05
|
|
|
barraquer-simons syndrome
|
[NCBI]
|
6.21752e-05
|
|
|
cri-du-chat syndrome
|
[NCBI]
|
6.21752e-05
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
5.6578e-05
|
|
|
CJD
|
[NCBI]
|
5.5575e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
4.64347e-05
|
|
|
C1QA
|
[NCBI]
|
4.30716e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
4.30716e-05
|
|
|
MBP
|
[NCBI]
|
4.28076e-05
|
|
|
PD
|
[NCBI]
|
4.00393e-05
|
|
|
EGF
|
[NCBI]
|
3.93817e-05
|
|
|
ALMS
|
[NCBI]
|
3.81958e-05
|
|
|
HRG
|
[NCBI]
|
3.57621e-05
|
|
|
HLA-B
|
[NCBI]
|
3.04319e-05
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
3.01199e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
2.88555e-05
|
|
|
response gene to complement 32
|
[NCBI]
|
2.80444e-05
|
|
|
CDW52
|
[NCBI]
|
2.80444e-05
|
|
|
DOM3Z
|
[NCBI]
|
2.80444e-05
|
|
|
C1RL
|
[NCBI]
|
2.80444e-05
|
|
|
VEGF
|
[NCBI]
|
2.718e-05
|
|
|
NEM3
|
[NCBI]
|
2.65691e-05
|
|
|
C4A
|
[NCBI]
|
2.63109e-05
|
|
|
PRF1
|
[NCBI]
|
2.61016e-05
|
|
|
HSPA1B
|
[NCBI]
|
2.52496e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.45509e-05
|
|
|
APCS
|
[NCBI]
|
2.38827e-05
|
|
|
A2M
|
[NCBI]
|
2.37185e-05
|
|
|
CD109
|
[NCBI]
|
2.34371e-05
|
|
|
CFHR5
|
[NCBI]
|
2.34371e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.29305e-05
|
|
|
EHMT2
|
[NCBI]
|
2.20912e-05
|
|
|
MASP2
|
[NCBI]
|
2.20912e-05
|
|
|
HLA-F
|
[NCBI]
|
2.20912e-05
|
|
|
HLA-E
|
[NCBI]
|
2.20912e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.15175e-05
|
|
|
CFHR4
|
[NCBI]
|
2.102e-05
|
|
|
HSPA1L
|
[NCBI]
|
2.102e-05
|
|
|
PRL
|
[NCBI]
|
2.03124e-05
|
|
|
NGFB
|
[NCBI]
|
1.93766e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
1.937e-05
|
|
|
VTN
|
[NCBI]
|
1.937e-05
|
|
|
CLU
|
[NCBI]
|
1.93376e-05
|
|
|
SEMA5A
|
[NCBI]
|
1.8706e-05
|
|
|
ELOVL4
|
[NCBI]
|
1.8706e-05
|
|
|
HTRA1
|
[NCBI]
|
1.81169e-05
|
|
|
EGFR
|
[NCBI]
|
1.78644e-05
|
|
|
RP
|
[NCBI]
|
1.77896e-05
|
|
|
CSPG2
|
[NCBI]
|
1.75876e-05
|
|
|
CR2
|
[NCBI]
|
1.75876e-05
|
|
|
MPO
|
[NCBI]
|
1.71651e-05
|
|
|
AL-A1
|
[NCBI]
|
1.71073e-05
|
|
|
IL2
|
[NCBI]
|
1.67981e-05
|
|
|
FCGR2B
|
[NCBI]
|
1.66676e-05
|
|
|
NLRP3
|
[NCBI]
|
1.66676e-05
|
|
|
FUT3
|
[NCBI]
|
1.66676e-05
|
|
|
LRP1
|
[NCBI]
|
1.6316e-05
|
|
|
prekallikrein deficiency
|
[NCBI]
|
1.49007e-05
|
|
|
CLDN11
|
[NCBI]
|
1.49007e-05
|
|
|
THY1
|
[NCBI]
|
1.46102e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.46102e-05
|
|
|
TH
|
[NCBI]
|
1.4587e-05
|
|
|
CCR2
|
[NCBI]
|
1.40746e-05
|
|
|
CR1
|
[NCBI]
|
1.35903e-05
|
|
|
HSPA1A
|
[NCBI]
|
1.31484e-05
|
|
|
CRP
|
[NCBI]
|
1.29413e-05
|
|
|
CD
|
[NCBI]
|
1.2902e-05
|
|
|
TPO
|
[NCBI]
|
1.27221e-05
|
|
|
DIABLO
|
[NCBI]
|
1.2367e-05
|
|
|
C1NH
|
[NCBI]
|
1.2018e-05
|
|
|
EPO
|
[NCBI]
|
1.17473e-05
|
|
|
CFI
|
[NCBI]
|
1.13865e-05
|
|
|
VIP
|
[NCBI]
|
1.12414e-05
|
|
|
FN1
|
[NCBI]
|
1.08276e-05
|
|
|
MST1
|
[NCBI]
|
1.00947e-05
|
|
|
TG
|
[NCBI]
|
9.71696e-06
|
|
|
VLDLR
|
[NCBI]
|
9.66223e-06
|
|
|
AD
|
[NCBI]
|
9.60353e-06
|
|
|
PZP
|
[NCBI]
|
9.46008e-06
|
|
|
HS
|
[NCBI]
|
9.36219e-06
|
|
|
WT1
|
[NCBI]
|
9.08036e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.04161e-06
|
|
|
temporal arteritis
|
[NCBI]
|
8.91701e-06
|
|
|
KLK3
|
[NCBI]
|
8.03406e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
7.84181e-06
|
|
|
AFP
|
[NCBI]
|
7.56852e-06
|
|
|
AR
|
[NCBI]
|
7.35293e-06
|
|
|
F2R
|
[NCBI]
|
7.23658e-06
|
|
|
CCL2
|
[NCBI]
|
7.17677e-06
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
6.76536e-06
|
|
|
TNF
|
[NCBI]
|
6.43121e-06
|
|
|
PCNA
|
[NCBI]
|
6.34201e-06
|
|
|
APOE
|
[NCBI]
|
6.32482e-06
|
|
|
WT1
|
[NCBI]
|
6.10838e-06
|
|
|
VRNI
|
[NCBI]
|
5.87292e-06
|
|
|
ADA
|
[NCBI]
|
5.61801e-06
|
|
|
GUSB
|
[NCBI]
|
5.57215e-06
|
|
|
GFAP
|
[NCBI]
|
5.42172e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
4.95244e-06
|
|
|
MAG
|
[NCBI]
|
4.87348e-06
|
|
|
CHAT
|
[NCBI]
|
4.66401e-06
|
|
|
CEACAM5
|
[NCBI]
|
4.50719e-06
|
|
|
STAT5A
|
[NCBI]
|
4.24045e-06
|
|
|
SLPI
|
[NCBI]
|
4.1312e-06
|
|
|
RA
|
[NCBI]
|
4.03669e-06
|
|
|
HP
|
[NCBI]
|
4.02365e-06
|
|
|
PF4
|
[NCBI]
|
3.60727e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
3.28228e-06
|
|
|
F3
|
[NCBI]
|
2.8093e-06
|
|
|
FAAH
|
[NCBI]
|
2.64447e-06
|
|
|
FMF
|
[NCBI]
|
2.40522e-06
|
|
|
PLG
|
[NCBI]
|
2.21133e-06
|
|
|
SDC2
|
[NCBI]
|
1.68021e-06
|
|
|
IAPP
|
[NCBI]
|
1.36816e-06
|
|
|
LDLR
|
[NCBI]
|
1.26442e-06
|
|
|
GPI
|
[NCBI]
|
1.16714e-06
|
|
|
HBA1
|
[NCBI]
|
1.11322e-06
|
|
|
TF
|
[NCBI]
|
1.03658e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
9.48228e-07
|
|
|
BL
|
[NCBI]
|
9.21138e-07
|
|
|
RNASE3
|
[NCBI]
|
8.95914e-07
|
|
|
ACE
|
[NCBI]
|
3.81649e-07
|
|
|
MG
|
[NCBI]
|
1.04639e-07
|
|
|
G6PD
|
[NCBI]
|
7.75566e-08
|
|
|
CVID
|
[NCBI]
|
7.50971e-08
|
|
|
POMC
|
[NCBI]
|
6.5754e-08
|
|
|
ALB
|
[NCBI]
|
5.74785e-08
|
|
|
XDH
|
[NCBI]
|
5.50389e-08
|
|
|
ACHE
|
[NCBI]
|
2.80827e-09
|
|